Product Information
PERSERIS ER 120 MG SYRINGE KIT is a brand product labeled by Indivior Inc., priced at $2765.5161 per EA under NDC 12496012001. Its NADAC has been published 166 times since Jun 21, 2023.
FDA first approved this application on Jul 27, 2018.
The High Outlier badge above means this manufacturer's average price in the Risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Indivior Inc.NDC
12496012001
Classification
Brand
Dosage Form
KIT
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA210655FDA Approved
7/27/2018
On Market Since
11/9/2018
Price Statistics
The NADAC for PERSERIS ER 120 MG SYRINGE KIT has been published 166 times since Jun 21, 2023, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2765.5161 per EA |
|---|---|
| All-time high | $2786.2219 (Feb 11, 2026) |
| All-time low | $2639.3240 (Jun 21, 2023) |
| 52-week high | $2786.2219 |
| 52-week low | $2761.2209 |
| Median price | $2767.5389 |
| Average price | $2747.3382 |
| Largest weekly change | +5.0% (Jan 3, 2024) |
| Weeks tracked | 166 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 87% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PERSERIS ER 120 MG SYRINGE KIT?
The current National Average Drug Acquisition Cost (NADAC) for PERSERIS ER 120 MG SYRINGE KIT, manufactured by Indivior Inc., is $2765.5161 per EA (NDC 12496012001), effective Aug 19, 2026.
How has the price of PERSERIS ER 120 MG SYRINGE KIT changed over time?
Over the history we have for it, the NADAC for PERSERIS ER 120 MG SYRINGE KIT has risen 4.8%. It has been tracked across 166 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for PERSERIS ER 120 MG SYRINGE KIT?
Since Jun 21, 2023, the NADAC for PERSERIS ER 120 MG SYRINGE KIT has ranged from a low of $2639.3240 (Jun 21, 2023) to a high of $2786.2219 (Feb 11, 2026), with a median of $2767.5389 per EA.
Are there cheaper alternatives to PERSERIS ER 120 MG SYRINGE KIT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RISPERIDONE ER 25 MG VIAL, is $353.4887 per EA — about 87% below PERSERIS ER 120 MG SYRINGE KIT.
Who manufactures PERSERIS ER 120 MG SYRINGE KIT?
PERSERIS ER 120 MG SYRINGE KIT (NDC 12496012001) is labeled by Indivior Inc., and CMS classifies it as a brand product.